Skip to main content

Animations

MJFF Publications

5051 - 5060 of 6420 Results
Title
Year
  • Year
  • 2011
  • 2024
  • 2025
  • 2021
  • 2024
  • 2023
  • 2015
  • 2016
  • 2025
  • 2024
  • Summary Details
    OPEN
    Title: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin America
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003
    Citation Count: 17
  • Summary Details
    OPEN
    Title: α‐Synuclein Pathology in PRKN‐Linked Parkinson's Disease: New Insights from a Blood‐Based Seed Amplification Assay
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.26917
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Copper supplementation mitigates Parkinson-like wild-type SOD1 pathology and nigrostriatal degeneration in a novel mouse model
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-025-02048-2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Predictors of stress resilience in Parkinson’s disease and associations with symptom progression
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00692-4
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Externally validated deep learning model to identify prodromal Parkinson’s disease from electrocardiogram
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-38782-7
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Targeting β-arrestin2 in the treatment ofl-DOPA–induced dyskinesia in Parkinson’s disease
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1502740112
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Cognitive Performance Patterns in Healthy Individuals with Substantia Nigra Hyperechogenicity and Early Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2016.00271
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Parkinson’s Disease Caregiving, Level of Care Burden, Caregiving-Related Strain, and Caregiver Health
    Journal Name: Healthcare
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/healthcare13131520
    Citation Count: 0
  • Summary Details
    OPEN
    Title: SARS-CoV-2 infection causes dopaminergic neuron senescence
    Journal Name: Cell Stem Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.stem.2023.12.012
    Citation Count: 75
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.